Roth Capital comments on Galena Biopharma (Nasdaq: GALE) after the company announced the dosing of the first patient in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE